Neuropsychopharmacology
Journal of Psychopharmacology
European Neuropsychopharmacology
Psychopharmacology
- Antipsychotic potential of the type 1 cannabinoid receptor positive allosteric modulator GAT211: preclinical in vitro and in vivo studies5 years ago
- A randomized phase 1 single-dose polysomnography study of ASP8062, a GABA B receptor positive allosteric modulator5 years ago
- Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants5 years ago
- Differential effects of d – and l -enantiomers of govadine on distinct forms of cognitive flexibility and a comparison with dopaminergic drugs5 years ago
- The acute effects of classic psychedelics on memory in humans5 years ago
- Lever-press duration as a measure of frustration in sucrose and drug reinforcement5 years ago
- Is the decrease in NO x due to a lack of substrate or a NOS inhibition in patients with major depression?5 years ago
International Journal of Neuropsychopharmacology
Frontiers in Pharmacology
Translational Psychiatry
Molecular Psychiatry
Nature Reviews Neuroscience
CNS Spectrum
Neuropharmacology
Nature
- International environmental treaties cannot be reformed through rational design6 months ago
- Hydrogen fuel isn’t always the green choice6 months ago
- What is the future of intelligence? The answer could lie in the story of its evolution6 months ago
- Why the global economic system should value life on our planet, not exploit it6 months ago
- The Internet is broken and the inventor of the World Wide Web wants to fix it6 months ago
- A ten-year drive to credit authors for their work — and why there’s still more to do6 months ago
- Chasing crayfish and the leeches that live on them6 months ago